DE60112768D1 - Behandlung von entzündlichen erkrankungen - Google Patents

Behandlung von entzündlichen erkrankungen

Info

Publication number
DE60112768D1
DE60112768D1 DE60112768T DE60112768T DE60112768D1 DE 60112768 D1 DE60112768 D1 DE 60112768D1 DE 60112768 T DE60112768 T DE 60112768T DE 60112768 T DE60112768 T DE 60112768T DE 60112768 D1 DE60112768 D1 DE 60112768D1
Authority
DE
Germany
Prior art keywords
treatment
inflammatory diseases
mefloquine
administration
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60112768T
Other languages
English (en)
Other versions
DE60112768T2 (de
Inventor
Benjamin Mark Skead
Robin Mark Bannister
Alan Rothaul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sosei R&D Ltd
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of DE60112768D1 publication Critical patent/DE60112768D1/de
Application granted granted Critical
Publication of DE60112768T2 publication Critical patent/DE60112768T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60112768T 2000-09-05 2001-08-31 Behandlung von entzündlichen erkrankungen Expired - Fee Related DE60112768T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0021776 2000-09-05
GBGB0021776.0A GB0021776D0 (en) 2000-09-05 2000-09-05 The treatment of inflammatory disorders
PCT/GB2001/003924 WO2002019994A2 (en) 2000-09-05 2001-08-31 The treatment of inflammatory disorders

Publications (2)

Publication Number Publication Date
DE60112768D1 true DE60112768D1 (de) 2005-09-22
DE60112768T2 DE60112768T2 (de) 2006-02-02

Family

ID=9898880

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60112768T Expired - Fee Related DE60112768T2 (de) 2000-09-05 2001-08-31 Behandlung von entzündlichen erkrankungen

Country Status (22)

Country Link
US (2) US7034028B2 (de)
EP (1) EP1315496B1 (de)
JP (1) JP2004508323A (de)
CN (1) CN1309388C (de)
AT (1) ATE302008T1 (de)
AU (2) AU2001284234B2 (de)
BR (1) BR0113646A (de)
CA (1) CA2419601A1 (de)
DE (1) DE60112768T2 (de)
DK (1) DK1315496T3 (de)
ES (1) ES2245372T3 (de)
GB (1) GB0021776D0 (de)
HK (1) HK1054324A1 (de)
HU (1) HUP0300934A2 (de)
IL (1) IL154419A0 (de)
MX (1) MXPA03001920A (de)
NO (1) NO323227B1 (de)
NZ (1) NZ524099A (de)
PL (1) PL364030A1 (de)
PT (1) PT1315496E (de)
WO (1) WO2002019994A2 (de)
ZA (1) ZA200301139B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021776D0 (en) * 2000-09-05 2000-10-18 Arakis Ltd The treatment of inflammatory disorders
GB0406014D0 (en) * 2004-03-17 2004-04-21 Arakis Ltd Pharmaceutical composition and use
WO2006108666A1 (en) * 2005-04-13 2006-10-19 Proteosys Ag Mefloquine, nelfinavir and saquinavir as novel agents for neurodegenerative and (neuro-) inflammatory diseases
WO2008075366A2 (en) * 2006-12-20 2008-06-26 Medwell Laboratories Ltd. Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
CA2804666A1 (en) * 2010-07-07 2012-01-12 Polymedix, Inc. Methods of immune modulation
CN113578299B (zh) * 2020-04-30 2023-11-10 中国石油化工股份有限公司 一种硅铝锆复合氧化物、催化裂化催化剂及其制备方法和应用
CN114452289B (zh) * 2020-12-31 2023-06-09 兰州大学 喹啉类衍生物在制备预防和/或治疗胃肠道疾病药物中的应用
CN114796216A (zh) * 2022-01-04 2022-07-29 南京医科大学 甲氟喹在防治全身代谢性炎症疾病中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8907518A (pt) * 1988-06-30 1991-05-28 Michael H Davis Processo para inibir a atividade do virus da imunodeficiencia humana(hiv)in vivo
CZ285937B6 (cs) * 1992-01-16 1999-12-15 Hoechst Aktiengesellschaft Arylcykloalkylové deriváty, způsob přípravy těchto derivátů a jejich použití
ES2118557T3 (es) * 1994-03-09 1998-09-16 Pfizer Compuestos de isoxazolina como inhibidores de la liberacion de tnf.
DK0966285T3 (da) 1997-03-07 2002-10-28 Vernalis Res Ltd Anvendelse af (+)mefloquin til behandling af malaria
EP0975345A1 (de) 1997-11-26 2000-02-02 Cerebrus Pharmaceuticals Limited (-)-mefloquine zur blockierung der purinrezeptoren und zur behandlung von bewegung- oder neurodegenerativen erkrankungen
CA2372443C (en) 1999-04-30 2010-07-13 Apt Pharmaceuticals, L.L.C. Local administration of anti-malarial agents for the treatment of inflammatory diseases
GB0021776D0 (en) * 2000-09-05 2000-10-18 Arakis Ltd The treatment of inflammatory disorders

Also Published As

Publication number Publication date
WO2002019994A2 (en) 2002-03-14
EP1315496B1 (de) 2005-08-17
ATE302008T1 (de) 2005-09-15
DK1315496T3 (da) 2005-11-14
AU8423401A (en) 2002-03-22
HK1054324A1 (en) 2003-11-28
GB0021776D0 (en) 2000-10-18
ZA200301139B (en) 2004-03-29
AU2001284234B2 (en) 2004-11-04
CN1452488A (zh) 2003-10-29
ES2245372T3 (es) 2006-01-01
NO323227B1 (no) 2007-02-05
NO20030985D0 (no) 2003-03-03
PT1315496E (pt) 2005-11-30
EP1315496A2 (de) 2003-06-04
US20060074106A1 (en) 2006-04-06
CA2419601A1 (en) 2002-03-14
US20040029916A1 (en) 2004-02-12
IL154419A0 (en) 2003-09-17
JP2004508323A (ja) 2004-03-18
BR0113646A (pt) 2004-01-06
NZ524099A (en) 2004-04-30
HUP0300934A2 (hu) 2003-11-28
US7034028B2 (en) 2006-04-25
PL364030A1 (en) 2004-12-13
DE60112768T2 (de) 2006-02-02
MXPA03001920A (es) 2004-02-12
WO2002019994A3 (en) 2002-05-16
NO20030985L (no) 2003-03-03
CN1309388C (zh) 2007-04-11

Similar Documents

Publication Publication Date Title
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
ATE350044T1 (de) Thrombopoietinmimetika
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
ATE315934T1 (de) Thrombopoietin-mimetika
ES2192839T3 (es) Timosina beta 4 oxidada.
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE60139466D1 (de) Behandlung von diabetes
IS2259B (is) Aðferð til meðferðar á netjuhersli með notkun mótlyfs við integríninu alfa-4 undireiningunni
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
ATE302008T1 (de) Behandlung von entzündlichen erkrankungen
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
TR200200278T2 (tr) Kalsilitik bileşimler
BR0115882A (pt) Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
ATE254595T1 (de) 2-amino-6-methyl-7-acetyl-tetralin und pharmazeutische zusammensetzungen zur vorbeugung und therapeutischen behandlung von entzündlichen und/oder autoimmunkrankheiten
DK1244438T3 (da) Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde
NO20005548D0 (no) Mykobakterieinhibitorer
DE60124093D1 (de) S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.
TR200003084T2 (tr) Paroxetine askorbat
ATE297745T1 (de) Chemische modifizierung von harn von säugern
ECSP982639A (es) Pequeñas moleculas utiles en el tratamiento de la enfermedad inflamatoria

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee